Skip to main content
Balaji Amines Ltd. logo

Balaji Amines Ltd. — Investor Relations & Filings

Ticker · BALAMINES ISIN · INE050E01027 LEI · 3358009DS8RG4Z8QBD69 BSE.NS Manufacturing
Open in API
Filings indexed 741 across all filing types
Latest filing 2025-11-21 Regulatory Filings
Country IN India
Listing BSE.NS BALAMINES

About Balaji Amines Ltd.

https://www.balajiamines.com/

Balaji Amines Ltd. is a leading manufacturer specializing in Aliphatic Amines, their derivatives, and specialty chemicals. The company produces a diverse range of products, including Methylamines, Ethylamines, and specialty chemicals such as N-Methyl-2-Pyrrolidone (NMP), Morpholine, Dimethylformamide (DMF), and Gamma-Butyrolactone (GBL). Its portfolio serves critical sectors including pharmaceuticals, agrochemicals, refineries, water treatment, and personal care. Utilizing advanced manufacturing technologies and vertically integrated processes, the company maintains a significant market presence in the production of amines and downstream derivatives. Balaji Amines is recognized for its large-scale production capacity and its role as a key supplier of essential chemical intermediates used in the synthesis of active pharmaceutical ingredients and crop protection chemicals.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement disclosure under SEBI Listing Regulations. It mentions the opening of a special window for re-lodgement of transfer requests of physical shares. The document is short (1409 characters) and serves as a regulatory announcement rather than a financial report or detailed filing. It does not contain financial data, management discussion, or report content. It is a regulatory disclosure under SEBI regulations, fitting best under Regulatory Filings (RNS).
2025-11-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Balaji Amines Limited for Q2 FY 2026, held on November 12, 2025. It includes detailed discussions of quarterly financial results, operational performance, future outlook, and Q&A with analysts. The text explicitly states it is an "Earnings Call Transcript" and contains the full dialogue of the call, including management remarks and analyst questions. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document is about 15,000 characters long, indicating it is a full transcript rather than a brief announcement or summary. Therefore, the correct classification is CT with high confidence.
2025-11-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing them about the recording of a conference call related to the Q2FY26 financial results. It mentions that the audio recording has been uploaded and that the transcript will be shared later. There is no actual financial data or detailed transcript included in this document. The document length is only 1487 characters, which is quite short and fits the pattern of an announcement rather than the full transcript or report. According to the rules, announcements about conference calls or transcripts without the full transcript text should be classified as Regulatory Filings (RNS).
2025-11-12 English
Copy of Newspaper Publication
Regulatory Filings
2025-11-12 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation on Q2FY26 Financial Results' and is addressed to stock exchanges referencing SEBI regulations. It contains detailed financial highlights for Q2FY26 and H1FY26, including standalone and consolidated profit and loss statements, balance sheets, project updates, and expansion plans. The content is structured as a presentation with slides and charts, focusing on financial performance, business updates, and future outlook. It is not a full annual or quarterly report but a detailed presentation aimed at investors summarizing recent financial results and strategic initiatives. Therefore, the document fits the category of an Investor Presentation (IP). The document length is substantial (15,000 characters), and it contains substantive financial data and business information, consistent with an investor presentation rather than a brief earnings release or regulatory filing.
2025-11-12 English
Press Release
Earnings Release Classification · 100% confidence The document is a press release announcing unaudited financial results for the quarter and half year ended September 30, 2025. It contains detailed financial highlights including revenue, EBITDA, PAT, and segment volumes for Q2FY26 and H1FY26. The document also discusses operational updates, new projects, and outlook commentary from the Managing Director. It is explicitly titled as a "Press Release" and provides key financial metrics and business updates typical of an Earnings Release. The document is about 10,287 characters long, which is sufficient to contain substantive financial data and analysis, not just a brief announcement or link to a report. Therefore, it is not a Report Publication Announcement or Regulatory Filing. It is not a full Annual Report or Interim Report but a quarterly earnings announcement. Hence, the appropriate classification is Earnings Release (ER).
2025-11-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.